Sequencing Study Suggests Mutation Selection Behind Glitches in Therapy-related AML | GenomeWeb

NEW YORK (GenomeWeb) – The risk of developing tricky-to-treat leukemia in the years following treatment for other types of cancer appears to reflect selection for cells containing treatment resistance-related mutations that are already circulating in the body, according to a new study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.